D-dimer testing to determine the duration of anticoagulation therapy G Palareti, B Cosmi, C Legnani, A Tosetto, C Brusi, A Iorio, V Pengo, ... New England Journal of Medicine 355 (17), 1780-1789, 2006 | 929 | 2006 |
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis S Siragusa, B Cosmi, F Piovella, J Hirsh, JS Ginsberg The American journal of medicine 100 (3), 269-277, 1996 | 597 | 1996 |
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH C Kearon, W Ageno, SC Cannegieter, B Cosmi, GJ Geersing, PA Kyrle Journal of Thrombosis and Haemostasis 14 (7), 1480-1483, 2016 | 483 | 2016 |
Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped G Palareti, C Legnani, B Cosmi, G Guazzaloca, C Pancani, S Coccheri Thrombosis and haemostasis 87 (01), 7-12, 2002 | 438 | 2002 |
Comparison between different D‐D imer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study G Palareti, C Legnani, B Cosmi, E Antonucci, N Erba, D Poli, S Testa, ... International Journal of Laboratory Hematology 38 (1), 42-49, 2016 | 429 | 2016 |
Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of … G Palareti, C Legnani, B Cosmi, L Valdré, B Lunghi, F Bernardi, ... Circulation 108 (3), 313-318, 2003 | 383 | 2003 |
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis J Douketis, A Tosetto, M Marcucci, T Baglin, B Cosmi, M Cushman, ... Bmj 342, 2011 | 359 | 2011 |
Bleeding with anticoagulation therapy–who is at risk, and how best to identify such patients G Palareti, B Cosmi Thrombosis and haemostasis 102 (08), 268-278, 2009 | 289 | 2009 |
High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism A Tripodi, C Legnani, V Chantarangkul, B Cosmi, G Palareti, ... Journal of thrombosis and haemostasis 6 (8), 1327-1333, 2008 | 226 | 2008 |
D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study G Palareti, B Cosmi, C Legnani, E Antonucci, V De Micheli, A Ghirarduzzi, ... Blood, The Journal of the American Society of Hematology 124 (2), 196-203, 2014 | 197 | 2014 |
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study B Cosmi, C Legnani, A Tosetto, V Pengo, A Ghirarduzzi, S Testa, D Prisco, ... Blood 115 (3), 481-488, 2010 | 194 | 2010 |
Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European independent foundation in angiology … GT Gerotziafas, M Catalano, MP Colgan, Z Pecsvarady, JC Wautrecht, ... Thrombosis and haemostasis 120 (12), 1597-1628, 2020 | 185 | 2020 |
Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease. Categorization of patients as having provoked or unprovoked venous … C Kearon, W Ageno, SC Cannegieter, B Cosmi, GJ Geersing, PA Kyrle J Thromb Haemost 14 (7), 1480-1483, 2016 | 176 | 2016 |
High plasma levels of factor VIII and risk of recurrence of venous thromboembolism L Cristina, C Benilde, C Michela, F Mirella, G Giuliana, P Gualtiero British journal of haematology 124 (4), 504-510, 2004 | 157 | 2004 |
Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants S Testa, O Paoletti, C Legnani, C Dellanoce, E Antonucci, B Cosmi, ... Journal of Thrombosis and Haemostasis 16 (5), 842-848, 2018 | 156 | 2018 |
Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) M Di Nisio, F Baudo, B Cosmi, A D'Angelo, A De Gasperi, A Malato, ... Thrombosis research 129 (5), e177-e184, 2012 | 154 | 2012 |
Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study G Palareti, B Cosmi, G Lessiani, G Rodorigo, G Guazzaloca, C Brusi, ... Thrombosis and haemostasis 104 (11), 1063-1070, 2010 | 144 | 2010 |
Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting: clues for the management of patients with an … A Rubboli, M Milandri, C Castelvetri, B Cosmi Cardiology 104 (2), 101-106, 2005 | 144 | 2005 |
Comparison of the non-specific binding of unfractionated heparin and low molecular weight heparin (Enoxaparin) to plasma proteins E Young, B Cosmi, J Weitz, J Hirsh Thrombosis and haemostasis 70 (10), 625-630, 1993 | 140 | 1993 |
A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture G Agnelli, B Cosmi, P Di Filippo, V Ranucci, F Veschi, M Longetti, ... Thrombosis and haemostasis 67 (02), 203-208, 1992 | 137 | 1992 |